Macitentan D4 (ACT-064992 D4) is a deuterium labeled Sulfamethoxazole. Macitentan has the potential for idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).Macitentan is an orally active, non-peptide dual ETA and ETB (endothelin) receptor antagonist.

1258428-05-5

C19H20Br2N6O4S

592.3

ACT-064992 D4;Macitentan D4;Macitentan-d4

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years